| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.16 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |